Cargando…
Niclosamide—A promising treatment for COVID‐19
Vaccines have reduced the transmission and severity of COVID‐19, but there remains a paucity of efficacious treatment for drug‐resistant strains and more susceptible individuals, particularly those who mount a suboptimal vaccine response, either due to underlying health conditions or concomitant the...
Autores principales: | Singh, Shivani, Weiss, Anne, Goodman, James, Fisk, Marie, Kulkarni, Spoorthy, Lu, Ing, Gray, Joanna, Smith, Rona, Sommer, Morten, Cheriyan, Joseph |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9111792/ https://www.ncbi.nlm.nih.gov/pubmed/35348204 http://dx.doi.org/10.1111/bph.15843 |
Ejemplares similares
-
muLTi-Arm Therapeutic study in pre-ICu patients admitted with Covid-19-Experimental drugs and mechanisms (TACTIC-E): A structured summary of a study protocol for a randomized controlled trial
por: Lu, Ing Ni, et al.
Publicado: (2020) -
Single-dose pharmacokinetics and lung function of nebulized niclosamide ethanolamine in sheep
por: Weiss, Anne, et al.
Publicado: (2023) -
Niclosamide as a Promising Therapeutic Player in Human Cancer and Other Diseases
por: Wang, Zhan, et al.
Publicado: (2022) -
A randomized, double-blind, placebo-controlled phase 1 trial of inhaled and intranasal niclosamide: A broad spectrum antiviral candidate for treatment of COVID-19
por: Backer, Vibeke, et al.
Publicado: (2021) -
Repurposed immunomodulatory drugs for Covid-19 in pre-ICu patients - mulTi-Arm Therapeutic study in pre-ICu patients admitted with Covid-19 – Repurposed Drugs (TACTIC-R): A structured summary of a study protocol for a randomised controlled trial
por: Kulkarni, Spoorthy, et al.
Publicado: (2020)